Ephraim Starr Biography and Net Worth

Senior Vice President, General Counsel & Corporate Secretary of Azenta

Mr. Starr joined Azenta Life Sciences in May 2025 as Senior Vice President, General Counsel & Corporate Secretary, overseeing all aspects of the company’s legal affairs. His responsibilities include corporate governance, intellectual property, securities, commercial contracts, litigation, compliance, and regulatory matters. He also serves as Secretary to both the Corporation and its Board of Directors.

With over 30 years of legal and business experience across the life sciences, water, computing, and industrial sectors, Mr. Starr brings a wealth of strategic and operational expertise. Prior to joining Azenta, he led the Private Equity Practice at Lean Focus, a consulting firm recognized for cultivating high-performance cultures and driving sustainable, profitable growth. Previously, Mr. Starr served as General Counsel and Corporate Officer at PHC Holdings, where he played a key role in taking the company public and establishing its M&A and governance frameworks. He has also held executive legal roles at Danaher, Lenovo, and Honeywell, where he championed operational efficiency, innovation, and strategic risk management to support business growth. Mr. Starr began his legal career in the intellectual property and litigation departments of Kirkland & Ellis LLP.

He holds a J.D. from Duke University School of Law and a B.A. in English and Physics from Amherst College. He is a registered U.S. Patent Attorney and is licensed to practice law in California and Colorado.

What is Ephraim Starr's net worth?: The estimated net worth of Ephraim Starr is at least $2.10 million as of July 31st, 2026. Mr. Starr owns 68,728 shares of Azenta stock worth more than $2,103,420 as of August 5th. This net worth estimate does not reflect any other investments that Mr. Starr may own. Learn More about Ephraim Starr's net worth.
How do I contact Ephraim Starr?: The corporate mailing address for Mr. Starr and other Azenta executives is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. Azenta can also be reached via phone at (978) 262-2400 and via email at [email protected]. Learn More on Ephraim Starr's contact information.
Has Ephraim Starr been buying or selling shares of Azenta?: During the last ninety days, Ephraim Starr has bought $8,096.95 of Azenta stock. Most recently, on Friday, July 31st, Ephraim Starr bought 335 shares of Azenta stock. The stock was acquired at an average cost of $24.17 per share, with a total value of $8,096.95. Following the completion of the transaction, the senior vice president now directly owns 68,728 shares of the company's stock, valued at $1,661,155.76. Learn More on Ephraim Starr's trading history.
Who are Azenta's active insiders?: Azenta's insider roster includes William Cornog (Director), Kimberly Crowley (SVP), Linda De Jesus (Insider), David Gray (SVP, Chief Strategy & New Business Officer), John Marotta (President & Chief Executive Officer), Olga Pirogova (SVP), and Ephraim Starr (Senior Vice President, General Counsel & Corporate Secretary). Learn More on Azenta's active insiders.
Are insiders buying or selling shares of Azenta?: During the last year, Azenta insiders bought shares 1 times. They purchased a total of 335 shares worth more than $8,096.95. The most recent insider tranaction occured on July, 31st when SVP Ephraim Starr bought 335 shares worth more than $8,096.95. Insiders at Azenta own 10.9% of the company. Learn More about insider trades at Azenta.
Information on this page was last updated on 7/31/2026.

Ephraim Starr Insider Trading History at Azenta

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/31/2026	Buy	335	$24.17	$8,096.95	68,728

Ephraim Starr Buying and Selling Activity at Azenta

Azenta Company Overview

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $31.48

$29.21

$31.38

50 Day Range

MA: $25.07

$21.34

$30.13

2 Week Range

Now: $31.48

$15.93

$41.73

Volume

513,962 shs

Average Volume

929,519 shs

Market Capitalization

$1.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37